MedPath

Effect of probiotic and selenium co-supplementation in the treatment of schizophrenia patients

Phase 3
Conditions
Schizophrenia.
Schizophrenia
Registration Number
IRCT20170513033941N41
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with schizophrenia
Individuals aged 18 to 60 years.

Exclusion Criteria

patients with metabolic syndrome
diabetes mellitus
liver and kidney insufficiency
thyroid disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Positive and Negative Syndrome Scale (PANSS). Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Clinical Examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath